OMP-18R5
18R5-001
Phase 1 mab completed
Quick answer
OMP-18R5 for Solid Tumors is a Phase 1 program (mab) at Mereo BioPharma Group plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mereo BioPharma Group plc
- Indication
- Solid Tumors
- Phase
- Phase 1
- Modality
- mab
- Status
- completed